Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
613.00    6.00 (0.99%)
Bid:
610.00
Ask:
612.00
Spread: 2.00 (0.328%)
Market Cap: £680.28m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Trading Update

25 Jan 2019 07:00

RNS Number : 0641O
Barr(A.G.) PLC
25 January 2019
 

 

 

IMMEDIATE RELEASE 25 January 2019

A.G. BARR p.l.c.

("A.G. BARR")

Trading Update

A.G. BARR p.l.c., which produces and markets some of the UK's leading drinks brands, including IRN-BRU, Rubicon, Strathmore and Funkin, today announces a pre-close trading update in respect of the financial year (52 weeks) ending 26 January 2019.

 

We are pleased to report a continued positive trading performance across the period with revenue expected to be c.£277m, up c.5% on the prior year (2017/18 : £264.1m1).

 

Strong trading execution across our core brands and the continued success of our key innovation have led to further market share volume gains in a UK soft drinks market which saw volume up 3.0% while value increased by 8.0% (Source : IRI Marketplace 48 weeks to 30 December 2018).

 

The impact of the Soft Drinks Industry Levy has been evident across the UK soft drinks market with value growth significantly outstripping volume in the period. Having taken the opportunity to drive our volume growth during this period, we expect to return to a more value-led trading strategy in 2019.

 

Throughout the year we have remained committed to investing across our brands, assets and people which, while supporting our growth, has had a moderate impact on operating margin.

 

Our tight control on costs has been maintained and our balance sheet remains robust. The £30m share repurchase programme has continued and we now expect it to complete during the course of 2019, slightly later than previously indicated.

 

For the financial year ending 26 January 2019, we remain confident of delivering profit ahead of the prior year and in line with the Board's expectations.

 

Outlook

Looking ahead, the current political and economic uncertainty in the UK looks set to continue. For the soft drinks industry, further regulatory intervention is on the horizon and consumer dynamics continue to evolve. Our strong and flexible business model, our portfolio of differentiated and growing brands and our well-invested and efficient asset base give us confidence for continued profitable growth as we enter a new financial year.

 

A.G. BARR intends to announce its full year financial results on 26 March 2019.

 

For further information, please contact:

 

A.G. BARR

Tel: 0330 390 3900

Roger White, Chief Executive

Stuart Lorimer, Finance Director

 

Instinctif Partners

Tel: 020 7457 2020

Justine Warren

Matthew Smallwood

 

 

1 All numbers reflect the adoption of IFRS 15 "Revenue from Contracts with Customers". Certain costs payable to customers, previously presented as expenses, are now shown as a deduction to revenue. There has been a £13.6m restatement to the prior year to enable an accurate comparison of performance.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTEAXFLADDNEFF
Date   Source Headline
3rd Jun 20267:00 amRNS-RLaunch of IRN-BRU Summer Campaign
27th May 20263:00 pmRNSDirector/PDMR Shareholding
26th May 20261:30 pmRNSDirector/PDMR Shareholding
22nd May 20262:00 pmRNSResult of AGM
11th May 20262:46 pmRNSDirector/PDMR Shareholding
21st Apr 202610:43 amRNSAnnual Report and Accounts and Notice of AGM
16th Apr 20267:00 amRNSDirector/PDMR Shareholding
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
13th Apr 20269:39 amRNSDirector/PDMR Shareholding
7th Apr 202611:21 amRNSDirector/PDMR Shareholding
1st Apr 20268:44 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSFinal Results
23rd Mar 20267:00 amRNS-RLaunch of IRN-BRU 'ZERO'
10th Mar 20267:00 amRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSNotice of Results Presentation
9th Feb 20263:56 pmRNSDirector/PDMR Shareholding
4th Feb 20264:16 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSFull Year Trading Update
15th Jan 20267:00 amRNSDirectorate change
12th Jan 202611:00 amRNSDirector/PDMR Shareholding
8th Dec 20252:49 pmRNSDirector/PDMR Shareholding
19th Nov 20251:44 pmRNSHolding(s) in Company
17th Nov 20253:25 pmRNSDirector/PDMR Shareholding
10th Nov 20254:44 pmRNSDirector/PDMR Shareholding
10th Nov 20254:38 pmRNSDirector/PDMR Shareholding
8th Oct 20252:39 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSInterim Results
11th Sep 20252:00 pmRNSNotice of Results
10th Sep 20256:00 pmRNSDirector/PDMR Shareholding
28th Aug 20252:00 pmRNS2025 Annual General Meeting Update
12th Aug 20254:01 pmRNSDirector/PDMR Shareholding
1st Aug 20257:01 amRNSDirector Declaration
29th Jul 20257:00 amRNSTrading Statement
9th Jul 202511:00 amRNSAppointment of Non-Executive Director
8th Jul 20252:02 pmRNSDirector/PDMR Shareholding
3rd Jul 202511:09 amRNSDirector/PDMR Shareholding
11th Jun 202511:01 amRNSDirector/PDMR Shareholding
10th Jun 20254:20 pmRNSDirector/PDMR Shareholding
10th Jun 20252:02 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:00 amRNSCapital Markets Event
23rd May 20255:36 pmRNSResult of AGM
12th May 20251:54 pmRNSDirector/PDMR Shareholding
30th Apr 20259:15 amRNSPotential disposal of Strathmore Business
28th Apr 20253:16 pmRNSDirector/PDMR Shareholding
28th Apr 20253:15 pmRNSDirector/PDMR Shareholding
22nd Apr 202510:24 amRNSAnnual Financial Report
9th Apr 202511:23 amRNSDirector/PDMR Shareholding
8th Apr 20253:29 pmRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSResults for year ended 25 January 2025
10th Mar 20252:04 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.